Regulatory T cells in graft-versus-host disease
- 29 June 2006
- journal article
- review article
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 28 (1) , 25-29
Abstract
Alloreactive T cells present in a bone marrow transplant are responsible for graft-vs-host disease, but their depletion is associated with impaired engraftment, immunosuppression, and loss of the graft-vs-leukemia effect. The subpopulation of CD4+CD25+ immunoregulatory T cells was first identified based on its crucial role in the control of autoimmune processes, but they also play a role in alloreactive responses. Moreover, these cells could be used to develop innovative strategies in the field of transplantation and particularly to prevent graft-vs-host disease. Indeed, high numbers of CD4+CD25+ immunoregulatory T cells can modulate graft-vs-host disease if administered at the same time as allogeneic hematopoietic stem cell transplantation in mice. This review discusses various important issues regarding the possible use of CD4+CD25+ immunoregulatory T cells to modulate alloreactivity in hematopoietic stem cell transplantation.Keywords
This publication has 56 references indexed in Scilit:
- Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITRBlood, 2005
- Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host diseaseTransplantation and Cellular Therapy, 2004
- In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune DiabetesJournal of Experimental Medicine, 2004
- Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple SclerosisJournal of Experimental Medicine, 2004
- CD4+CD25+ Immunoregulatory T CellsJournal of Experimental Medicine, 2002
- Preterminal host dendritic cells in irradiated mice prime CD8+ T cell–mediated acute graft-versus-host diseaseJournal of Clinical Investigation, 2002
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxisThe Lancet, 1995
- Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated DonorsNew England Journal of Medicine, 1990
- Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.Journal of Experimental Medicine, 1986